|
¿ø¸®¿Í Ư¡ |
|||||||||||||||
- Áú·®±â¹Ý À¯¼¼Æ÷ºÐ¼®±â(Mass Cytometry)´Â °¢°¢ÀÇ ¼¼Æ÷¿¡ ´ëÇØ 40°³ ÀÌ»óÀÇ ´Ù¸¥ Ç×üÁ¤º¸µéÀ» µ¿½Ã¿¡ ÃøÁ¤ÇÔÀ¸·Î½á °¢ ¼¼Æ÷ÀÇ Ç¥ÇöÇü, ½ÅÈ£Àü´Þ °æ·Î ¹× ±â´É¿¡ ´ëÇؼ º¸´Ù Æ÷°ýÀûÀ¸·Î ÀÌÇØÇÒ ¼ö ÀÖ´Â °íÂ÷¿ø, ´ë¿ë·®ÀÇ µ¥ÀÌÅ͸¦ Á¦°øÇÔ.
- ÇöÀç ±âÃÊ »ý¸í°úÇבּ¸»Ó¸¸ ¾Æ´Ï¶ó ÀÓ»ó¿¡¼ °Ç°°ËÁø ¹× Áúº´Áø´ÜÀ» À§ÇØ ±¤¹üÀ§ÇÏ°Ô »ç¿ëµÇ°í ÀÖ´Â, ±âÁ¸ÀÇ Çü±¤±â¹Ý À¯¼¼Æ÷ºÐ¼®¹ý(Fluorescence-based Flow Cytometry)Àº ´ÜÀϼ¼Æ÷¼öÁØ¿¡¼ÀÇ ´Ù¾çÇÑ Á¤º¸¸¦ Á¦°øÇÏ´Â ¸Å¿ì ¿ì¼öÇÑ ¹ÙÀÌ¿À/ÀÇ·á ºÐ¼®ÀåºñÀÌÁö¸¸, ¼·Î ´Ù¸¥ Çü±¤ ½ÅÈ£µé °£ÀÇ Áßø ¹®Á¦(spillover)·Î ÀÎÇÏ¿© °¢ ¼¼Æ÷·Î ºÎÅÍ ¾òÀ» ¼ö ÀÖ´Â Á¤º¸ÀÇ ¼ö(»ê¶õ/Çü±¤ ä³ÎÀÇ ¼ö)°¡ Á¦ÇÑÀû(ÀϹÝÀûÀ¸·Î 5-10°³ ä³Î ÀÌÇÏ)ÀÎ ´ÜÁ¡ÀÌ ÀÖÀ½.
- ÀÌ¿¡ ºñÇÏ¿© Áú·®±â¹Ý À¯¼¼Æ÷ºÐ¼®±â(Mass Cytomerty)´Â Çü±¤ ºÐÀÚ ´ë½Å ÁÖ·Î ¶õźÁ· ±Ý¼ÓÀÌ Ç¥ÁöµÈ Ç×ü¸¦ »ç¿ëÇÏ°í, ÀÌµé ±Ý¼Ó¿ø¼Òµé°£ÀÇ Áú·® Â÷ÀÌ¿¡ ±â¹ÝÇÏ¿©, ¼¼Æ÷ÀÇ Ç¥¸é ¶Ç´Â ³»ºÎ¿¡ Á¸ÀçÇÏ´Â ¼ö¸¹Àº ´Ù¾çÇÑ Ç×üµéÀ» ´ÜÀϼ¼Æ÷ ¼öÁØ¿¡¼ 1Da(1amu)ÀÇ Áú·®ºÐÇØ´ÉÀ¸·Î ÃøÁ¤ÇÔ. µû¶ó¼, Ç×ü½ÅÈ£°£ÀÇ ÁßøÇö»óÀÌ ÃÖ¼ÒÈµÇ¾î °³º° ¼¼Æ÷´ç 30-50¿© ä³Î±îÁö Á¤º¸¸¦ ¾òÀ» ¼ö ÀÖÀ¸¸ç À̷κÎÅÍ ±âÁ¸ÀÇ Çü±¤±â¹Ý À¯¼¼Æ÷ ºÐ¼®¹ýÀÇ ÇѰ踦 ¶Ù¾î ³Ñ´Â °íÂ÷¿øÀÇ ´ë±Ô¸ð ´ÜÀϼ¼Æ÷ºÐ¼® µ¥ÀÌÅ͸¦ È®º¸ÇÒ ¼ö ÀÖÀ½.
- ¶ÇÇÑ Áú·®±â¹Ý À¯¼¼Æ÷ºÐ¼®±â´Â ¼¼Æ÷¿¡ °ÅÀÇ Á¸ÀçÇÏÁö ¾Ê´Â ÈñÅä·ù ¶õźÁ· ±Ý¼ÓµéÀ» Ç¥Áö¹°Áú·Î »ç¿ëÇϹǷΠ¹è°æ½ÅÈ£(background signal)ÀÇ ¼öÁØÀÌ ¸Å¿ì ³·°í, ÀÚ°¡Çü±¤(auto fluorescence)¹®Á¦µµ ÇØ°áµÇ¹Ç·Î, ¼¼Æ÷¿¡¼ ¾ÆÁÖ ¹Ì·®À¸·Î Á¸ÀçÇÏ´Â Ç×ü½ÅÈ£µµ ºÐ¼®ÀÌ °¡´ÉÇÔ.
- Áú·®±â¹Ý À¯¼¼Æ÷ºÐ¼®±â ½ÇÇèÀ» À§ÇÏ¿© ÇÊ¿äÇÑ ±Ý¼ÓÇ¥Áö Ç×üµéÀº ÇöÀç 630Á¾·ù ÀÌ»óÀÌ »ó¾÷ÀûÀ¸·Î ÆǸŰ¡ µÇ°í ÀÖÀ¸¸ç, ¿¬±¸ÀÚ°¡ ÀÌ¹Ì º¸À¯ÇÏ°í Àְųª Ưº°È÷ ¿øÇÏ´Â Ç×ü¿¡ ±Ý¼ÓÇ¥Áö¸¦ ¿øÇÒ °æ¿ì 35°¡ÁöÀÇ µ¿À§¿ø¼ÒÁß¿¡¼ ¼±ÅÃÇÏ¿© Á÷Á¢ Ç¥Áöµµ °¡´ÉÇÔ. |
|||||||||||||||
»ç¾ç |
|||||||||||||||
(1) Channels : > 40
(2) Mass range : 75 ~ 209 Da atomic analytical mass(135 channels)
(3) Abundance sensitivity : 0.2% ~ 0.4% for 159Tb
(4) Instrument response : < 600,000 counts/pg 159Tb
(5) Detection limit : up to 350 antibodies/cell
(6) Dynamic range : 3 ~ 5 orders of magnitude
(7) Calibration : Automated
(8) Peak throughput : > 1,000 events/sec
(9) Flow rate : > 20 §¡/min
(10) Replicate sample CV (normalized) : < 3% |
|||||||||||||||
½Ã·áÁغñ¹æ¹ý |
|||||||||||||||
- ´ã´çÀÚ¿¡°Ô º°µµ ¹®ÀÇ | |||||||||||||||
»ç¿ë·á |
|||||||||||||||
- ºÎ°¡¼¼ º°µµ |
|||||||||||||||
ºÐ¼®°á°úÇ¥Çö |
|||||||||||||||
[ SPADE Analysis of Mass Cytomery Data (Ha et al. (2019), Biorxiv, https://doi.org/10.1101/617332
[ t-SNE Analysis of Mass Cytomery Data (Ha et al. (2019), Biorxiv, https://doi.org/10.1101/617332 ] |